FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/01/011184 [Registered on: 08/01/2018] Trial Registered Prospectively
Last Modified On: 04/01/2018
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A trial to check the effect of Capsule and syrup Shwasi in the management of Shwas Roga w.s.r. to Bronchial Asthma. 
Scientific Title of Study   A clinical study to evaluate the efficacy and safety of ayurvedic formulations (Capsule and syrup Shwasi) in the management of Tamak Shwas w.s.r. to Bronchial Asthma  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Prof B L Mehra 
Designation  prof and head department of kayachikitsa 
Affiliation  rajiv gandhi govt post graduate ayurvedic college and hoapital Paprola 
Address  Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital Paprola

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418017615  
Fax    
Email  mehra_bl@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof B L Mehra 
Designation  prof and head department of kayachikitsa 
Affiliation  rajiv gandhi govt post graduate ayurvedic college and hoapital Paprola 
Address  Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital Paprola

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418017615  
Fax    
Email  mehra_bl@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof B L Mehra 
Designation  prof and head department of kayachikitsa 
Affiliation  rajiv gandhi govt post graduate ayurvedic college and hoapital Paprola 
Address  Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital Paprola
Adarsh colony Panthehar Teh Baijnath Distt Kangra
Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418017615  
Fax    
Email  mehra_bl@rediffmail.com  
 
Source of Monetary or Material Support  
Shree Dhanwantri Herbals Amritsar 
 
Primary Sponsor  
Name  Shree Dhanwantri Herbals Amritsar 
Address  Shree Dhanwantri Herbals Amritsar 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Prof B L Mehra  Paprola Ayurvedic Hospital  Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital Paprola Department of Kayachikitsa Room No 315 Hospital Building
Kangra
HIMACHAL PRADESH 
9418017615

mehra_bl@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Patients with Episodic Bronchial Asthma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Cap Shwasi and Syrup Shwasi  group 1- 2 Capsule(500mg) TID with water for 30 days group2- 10 ml TID + 2 Capsules(500mg) TID with water for 30 days 
Comparator Agent  nil  nil 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients willing for trial.
2. Age between 20 -60 years of either sex.
3. Patients presenting with clinical features of Tamak Shwas/Bronchial Asthma with impaired PFT.
 
 
ExclusionCriteria 
Details  1. Patients not willing for the trial or not ready to give informed consent.
2. Patients of age < 20 and above 60 years
3. Patients with Uncontrolled Hypertension and
Diabetes mellitus with complications.
4. Patients having malignancy, chronic cardiac illness, hepatic disorders, renal disorders, tuberculosis and other comorbid diseases.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Alternation 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
awaited  after every 15 days till completion of the trial 
 
Secondary Outcome  
Outcome  TimePoints 
awaited  every 15 days after initiating the therapy till completion of the trial  
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   19/01/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   none yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Respiration or breathing in and out is the evidence feature of life. The prevalence of respiratory disorders is increasing due to increasing pollution, overcrowding and poor hygiene. Tamak Shawas is a variety of Shwas roga associated with difficulty in breathing. Movement of air through the Pranvaha Sarotas is hampered in this disease resulting in the cry of the organ heading towards complete failure for want of air. Tamak Shwas well known for its episodic and chronic course which comes under the life threatening diseases. It is analogous to Bronchial Asthma in Modern system of medicine due to similarity in symptoms, pathogenesis, onset, causes and precipitating factors. Tamak shwas is characterized by paroxysmal attacks of breathlessness, cough, coryza and chest tightness, rapid respiration distress due to inability to expectorate and prolonged expiration.

The trial formulation Cap and Syrup Shwasi is a partial organic herbomineral preparation taken for clinical trial.

 
Close